Illumisoft Lighting Corp. has entered into a strategic product development engagement with Capgemini to accelerate its SaniLux 216 nanometre far UVC disinfection platform. The collaboration will support product design, engineering architecture, manufacturing readiness, and commercialization planning for the platform, which is intended for continuous use in high-occupancy indoor environments. Capgemini's frog and Synapse units will work alongside Illumisoft to advance SaniLux from its current technology development stage toward a manufacturable commercial product family. The SaniLux platform is designed to mitigate airborne pathogen risk in settings such as healthcare, transportation, and education, where conventional germicidal UV solutions are generally not suitable for occupied spaces. Illumisoft estimates the global market for ultraviolet disinfection technologies is in the multi-billion dollar range and growing at a double-digit compound annual rate.
Capgemini SEStrategic collaboration with Capgemini to advance SaniLux platform toward commercialization.